cellulosic ethenol and windfarms
Hong Kong Energy is upping their propellers and looking to invest in wind farms and piloting a cutting edge cellulosic ethanol project.
The first wind farm, a 100.5MW project co-developed by HKE and China Energy Conservation Investment Corporation, a Chinese clean energy developer, will be located in Lunanbao of Zhangbei County, Hebei Province. The installation will consist of 67 wind turbines each with 1.5MW power generating capacity. The project has already been approved by the government, and is slated to begin construction after June 2008 and is slated to be completed fourth-quarter of 2010.
In the interim, Hong Kong Energy is planning a 49.5MW wind farm in Siziwangqi, Inner Mongolia, which is awaiting governmental approval. The project will have 33 wind turbines of 1.5MW at a cost of CNY 480.5m (62 million us dollars). HKE hopes to break ground on the project in the latter half of 2008 and expects to complete construction by the end of 2009. Seperately, HKE announced that it signed a technology transfer and co-operation agreement with GeneHarbor, a biotech company, to build a pilot ethanol plant for testing and implemention of the cellulosic ethanol technology developed by GeneHarbor. A joint venture, Hong Kong (Biomass) Energy, will be set up to run the project in which HKE will hold a 55% stake and GeneHarbor the remaining 45%. In addition, the two parties decided to set up another venture, TechService, 90%-owned by HKE and 10% by GeneHarbor, for commercial exploitation of cellulosic ethanol and sale of related enzymes in China.
In the interim, Hong Kong Energy is planning a 49.5MW wind farm in Siziwangqi, Inner Mongolia, which is awaiting governmental approval. The project will have 33 wind turbines of 1.5MW at a cost of CNY 480.5m (62 million us dollars). HKE hopes to break ground on the project in the latter half of 2008 and expects to complete construction by the end of 2009. Seperately, HKE announced that it signed a technology transfer and co-operation agreement with GeneHarbor, a biotech company, to build a pilot ethanol plant for testing and implemention of the cellulosic ethanol technology developed by GeneHarbor. A joint venture, Hong Kong (Biomass) Energy, will be set up to run the project in which HKE will hold a 55% stake and GeneHarbor the remaining 45%. In addition, the two parties decided to set up another venture, TechService, 90%-owned by HKE and 10% by GeneHarbor, for commercial exploitation of cellulosic ethanol and sale of related enzymes in China.
